酸性pH大大增强了calbindin-D28K对caspase-3的抑制作用:对阿尔茨海默氏症治疗药物的影响
Jude Kinkead1, Richele J Thompson1, Morgan E Milton1
1Department of Biochemistry & Molecular Biology, Brody School of Medicine, East Carolina University, North Carolina, Greenville, USA.
Cell biochemistry and function
|December 23, 2025
概括
研究人员发现,pH值调节卡尔宾丁-D28K (D28K) 抑制阿尔茨海默病 (AD) 病原发生的关键酶酶-3 (Cas3). 这一发现确定了AD的新治疗点.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生化学
- 分子生物学分子生物学
背景情况:
- 阿尔茨海默氏病 (AD) 的发病包括像粉样蛋白前体蛋白 (APP) 和tau与caspase-3 (Cas3) 等蛋白质之间的相互作用.
- 卡斯巴-3 (Cas3) 是一种氨酸蛋白酶,与AD有关,其抑制是治疗标.
- 卡尔宾丁-D28K (D28K) 是一种特定的Cas3抑制剂,但其抑制的结构基础尚未完全理解.
研究的目的:
- 研究调节卡尔宾丁-D28K (D28K) 对卡斯巴-3 (Cas3) 的抑制功能的环境因素.
- 为了阐明负责Cas3抑制的D28K的特定构造.
- 在Cas3.3中确定D28K的结构目标.
主要方法:
- 下拉测试用于评估蛋白质相互作用.
- 卡斯巴酶-3 (Cas3) 抑制试验测量酶活性.
- 分子对接模拟用于预测结合相互作用.
主要成果:
- pH被确定为D28K对Cas3.3的抑制功效的关键调节者.
- D28K对Cas3的抑制强度可以根据pH调整.
- Cas3的Loop4被确定为D28K的特定结构元素.
结论:
- pH 是一个重要的环境因素,影响D28K和Cas3之间的相互作用.
- 了解pH依赖的抑制机制,可以了解AD的病原性.
- 针对D28K-Cas3相互作用,特别是Loop4,为阿尔茨海默病提供了潜在的治疗策略.
更多相关视频
14:57Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology
Published on: March 23, 2011
95.1K
08:41Caspase-3 Activity in the Rat Amygdala Measured by Spectrofluorometry After Myocardial Infarction
Published on: January 12, 2016
12.3K
相关概念视频
Caspases
13.6K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
13.6K
Alzheimer's Disease: Treatment
744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
3.7K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.7K
Calmodulin-dependent Signaling
5.9K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.9K
